Ranibizumab and conbercept for treating wet age-related macular degeneration in China: A systematic review and meta-analysis

BACKGROUND: This study aimed to evaluate the therapeutic effects of ranibizumab and conbercept on wet age-related macular degeneration. METHODS: Randomized controlled trials comparing ranibizumab and conbercept in the treatment of wet age-related macular degeneration were searched in the PubMed, Med...

Descripción completa

Detalles Bibliográficos
Autores principales: Pengfei, Jiang, Hanyu, Tan, Qinghua, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
4200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191391/
https://www.ncbi.nlm.nih.gov/pubmed/35049171
http://dx.doi.org/10.1097/MD.0000000000027774

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9191391/
https://www.ncbi.nlm.nih.gov/pubmed/35049171
http://dx.doi.org/10.1097/MD.0000000000027774

Ejemplares similares